Membranoproliferative Glomerulonephritis

Membranoproliferative glomerulonephritis is type of Chronic glomerulonephritis characterized histologically by proliferation of mesangial cells, increase in the mesangial extracellular matrix, and a thickening of the glomerular capillary walls. Discover the latest research on membranoproliferative glomerulonephritis here.

April 8, 2020
Case Report
Open Access

Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy

Case Reports in Nephrology
Jessica Cruz-WhitleyBrian Young
June 20, 2020
Review

C3 Glomerulopathy: Pathogenesis and Treatment

Advances in Chronic Kidney Disease
Syeda Behjat Ahmad, Andrew S Bomback
June 1, 2020
Open Access

Drusen in dense deposit disease: not just age-related macular degeneration

Lancet
Daniella Lent-Schochet, Glenn Yiu
July 15, 2020
Open Access

Utility of transjugular renal biopsy as an alternative to percutaneous biopsy

Nefrología : publicación oficial de la Sociedad Española Nefrologia
Mónica BoluferMaría José Soler
July 23, 2020
Case Report
Open Access

Diverse Clinical Presentations of C3 Dominant Glomerulonephritis

Frontiers in Medicine
Ramy M HannaIra Kurtz
July 6, 2020
Review

Practical management of C3 glomerulopathy and immunoglobulin-mediated MPGN: facts and uncertainties

Kidney International
Fadi FakhouriVéronique Frémeaux-Bacchi
May 5, 2020
Open Access

IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration

Annals of Hematology
Johannes RuheMartin Busch
July 1, 2020
Open Access

Nephrotic syndrome due to preeclampsia before 20 weeks of gestation: a case report

BMC Nephrology
Tomo SuzukiYugo Shibagaki
June 23, 2020
Open Access

ACTH Treatment for Management of Nephrotic Syndrome: A Systematic Review and Reappraisal

International Journal of Nephrology
Ronith ChakrabortyRupesh Raina
May 11, 2020
Open Access

Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy

Kidney International
Vicky BrocklebankDavid Kavanagh
April 27, 2020

Cryptococcosis in an HIV-negative, HCV positive, immunosenescent patient: a case report

The New Microbiologica
Marta ColaneriFabiola Lallitto
June 23, 2020
Preprint
Open Access

Clinical Presentation and Renal Histopathological Findings in Patients with Monoclonal Gammopathy and Kidney Disease

MedRxiv : the Preprint Server for Health Sciences
Gaetano AlfanoG. Cappelli

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/membranoproliferative-glomerulonephritis/33afa3e9-ecae-444b-a7e4-b8df4a5bbded